IL6 and colorectal carcinoma: In this paper, we propose a signature of sEV-bounded protein markers, specifically IL-6/CD81, IL-6/Cyclin D1, and the combination of all three these markers, to predict through liquid biopsy the potential relapse of patients who already experienced CRC conditions.